ForMyGluco
BlogGlossary← Home

Checks and prevention

Can complications be prevented?

· 3 min

Terrace steps of travertine; mineral tiers built up layer by layer over centuries, in warm ochre and cream tones.

There’s no path that zeroes out every complication; but balance built in the early period keeps having an effect even years later. Long follow-up studies gave this a name: metabolic memory. Full protection isn’t achieved under every condition, while delaying and easing are a measured result.

This question needs an honest answer. A complication isn’t fate; it’s a curve whose slope isn’t clear from the start. How steep it turns doesn’t hang on one thing; but heading the list is the course blood glucose takes over the years. The evidence for this comes not from one study but two independent long follow-ups.

The big type 1 diabetes trial split participants into two arms and followed them for years past its end. Once it closed, the arms’ averages converged; on paper the gap melted. Outcomes were expected to even out too. The opposite happened: the gap on the eye, kidney and nerve side didn’t close; it widened a while longer (Lachin et al., 2021).

Type 2 diabetes showed something similar too. After tight monitoring ended, the glucose gap between groups vanished within the very first year; the small-vessel advantage, in contrast, held ten years. The gap on heart attack and death, meanwhile, grew clearer as follow-up lengthened. The literature calls this picture the legacy effect.

The curve has one more feature. Nothing is felt while it builds: eye, kidney and nerves stay quiet early on. This quiet is measured in years, not days; pain doesn’t show where the curve stands, regular measurements and exams do. The screening article covers which exams make this silent stretch visible.

So how does the body remember this? Two explanations stand out. First: in long-lived tissue (vessel-wall collagen, the eye’s and kidney’s fine structures), glucose binds permanently to proteins; the bonds stay in place for years. Second: marks forming in how the cell reads its genes, marks that aren’t erased for a long time.

What was measuredWhat came out
Glucose held tighter early onEye, kidney and nerve involvement rarer for years
Once group averages evened outGap didn’t close; it widened a while longer
The effect’s lifespanLasts about ten years, then fades; banked gain stays
Balance built laterLeaves its own mark, doesn’t erase the period before

The hope here shouldn’t be overstated: the effect itself isn’t endless; it fades after a window of about ten years, leaving the banked gain. The same mechanism runs in reverse too: a stretch spent high leaves its own mark. That mark is quiet as well; no pain, it shows in a record spread over years. Better read this not as blame but as a measure of what putting it off costs.

A tree planted early in the garden tells this picture well. Its shade doesn’t show that day; it appears years later. A tree planted later gives shade too; it just doesn’t bring back the summers between. The real difference in front of the house isn’t planting day but unbroken care.

So the question doesn’t close with yes or no. Not every complication is stopped in every case; delay and easing, though, are a measured result. What’s more, the years gained aren’t taken back later.

Sources

  1. Lachin JM, Nathan DM; DCCT/EDIC Research Group. Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC). Diabetes Care. 2021;44(10):2216–2224. doi:10.2337/dc20-3097
  2. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes. N Engl J Med. 2008;359(15):1577–1589. doi:10.1056/NEJMoa0806470
  3. Nathan DM; DCCT/EDIC Research Group. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview. Diabetes Care. 2014;37(1):9–16. doi:10.2337/dc13-2112
  4. Türkiye Endokrinoloji ve Metabolizma Derneği (TEMD). Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu-2026. 17. Baskı. TEMD; 2026. ISBN 978-625-99759-8-6

This piece is for information only; it is not a diagnosis, treatment or dosing recommendation. Always make decisions about your treatment together with your doctor.

Start keeping your own record

ForMyGluco keeps your readings, medications and appointments in one place, and prepares a doctor-ready PDF in a single tap.

View on the App Store →

All of the blog